These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 31655429

  • 1. Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency.
    Shawky AM, Abourehab MAS, Abdalla AN, Gouda AM.
    Eur J Med Chem; 2020 Jan 01; 185():111780. PubMed ID: 31655429
    [Abstract] [Full Text] [Related]

  • 2. Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities.
    Attalah KM, Abdalla AN, Aslam A, Ahmed M, Abourehab MAS, ElSawy NA, Gouda AM.
    Bioorg Chem; 2020 Jan 01; 94():103371. PubMed ID: 31708230
    [Abstract] [Full Text] [Related]

  • 3. Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities.
    Gouda AM, Abdelazeem AH, Abdalla AN, Ahmed M.
    Acta Pharm; 2018 Sep 01; 68(3):251-273. PubMed ID: 31259695
    [Abstract] [Full Text] [Related]

  • 4. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents.
    Alegaon SG, Alagawadi KR, Garg MK, Dushyant K, Vinod D.
    Bioorg Chem; 2014 Jun 01; 54():51-9. PubMed ID: 24793214
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study.
    Abdel-Aziz AA, El-Azab AS, AlSaif NA, Alanazi MM, El-Gendy MA, Obaidullah AJ, Alkahtani HM, Almehizia AA, Al-Suwaidan IA.
    J Enzyme Inhib Med Chem; 2020 Dec 01; 35(1):610-621. PubMed ID: 32013633
    [Abstract] [Full Text] [Related]

  • 6. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA, Elshaier YAMM, Hassanein EHM, Abdellatif KRA.
    Bioorg Chem; 2020 May 01; 98():103752. PubMed ID: 32197148
    [Abstract] [Full Text] [Related]

  • 7. Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
    Moussa G, Alaaeddine R, Alaeddine LM, Nassra R, Belal ASF, Ismail A, El-Yazbi AF, Abdel-Ghany YS, Hazzaa A.
    Eur J Med Chem; 2018 Jan 20; 144():635-650. PubMed ID: 29289887
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH, El-Saadi MT, Safi El-Din AG, Omar HA, El-Moghazy SM.
    Bioorg Med Chem; 2017 Jan 15; 25(2):665-676. PubMed ID: 27916468
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z, Wang ZC, Yan XQ, Wang PF, Lu XY, Chen LW, Zhu HL, Zhang HW.
    Bioorg Med Chem Lett; 2015 May 01; 25(9):1947-51. PubMed ID: 25866240
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
    Palkar MB, Singhai AS, Ronad PM, Vishwanathswamy AH, Boreddy TS, Veerapur VP, Shaikh MS, Rane RA, Karpoormath R.
    Bioorg Med Chem; 2014 May 15; 22(10):2855-66. PubMed ID: 24751552
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
    Atatreh N, Youssef AM, Ghattas MA, Al Sorkhy M, Alrawashdeh S, Al-Harbi KB, El-Ashmawy IM, Almundarij TI, Abdelghani AA, Abd-El-Aziz AS.
    Bioorg Chem; 2019 May 15; 86():393-400. PubMed ID: 30763886
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
    Tageldin GN, Fahmy SM, Ashour HM, Khalil MA, Nassra RA, Labouta IM.
    Bioorg Chem; 2018 Aug 15; 78():358-371. PubMed ID: 29627656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Tewari AK, Singh VP, Yadav P, Gupta G, Singh A, Goel RK, Shinde P, Mohan CG.
    Bioorg Chem; 2014 Oct 15; 56():8-15. PubMed ID: 24893208
    [Abstract] [Full Text] [Related]

  • 15. Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition.
    Amin NH, Mohammed AA, Abdellatif KR.
    Future Med Chem; 2018 Jan 15; 10(1):53-70. PubMed ID: 29235887
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
    Huang Y, Zhang B, Li J, Liu H, Zhang Y, Yang Z, Liu W.
    Eur J Med Chem; 2019 Oct 15; 180():41-50. PubMed ID: 31299586
    [Abstract] [Full Text] [Related]

  • 17. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
    Abdelgawad MA, Labib MB, Abdel-Latif M.
    Bioorg Chem; 2017 Oct 15; 74():212-220. PubMed ID: 28865292
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
    Chaaban I, Rizk OH, Ibrahim TM, Henen SS, El-Khawass EM, Bayad AE, El-Ashmawy IM, Nematalla HA.
    Bioorg Chem; 2018 Aug 15; 78():220-235. PubMed ID: 29602046
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
    Zabiulla, Gulnaz AR, Mohammed YHE, Khanum SA.
    Bioorg Chem; 2019 Nov 15; 92():103220. PubMed ID: 31493708
    [Abstract] [Full Text] [Related]

  • 20. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core.
    Abdelall EKA, Lamie PF, Ahmed AKM, El-Nahass ES.
    Bioorg Chem; 2019 May 15; 86():235-253. PubMed ID: 30716621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.